Published in Clin Immunol on August 01, 2003
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol (2006) 1.43
B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol (2011) 1.08
SLE: translating lessons from model systems to human disease. Trends Immunol (2005) 1.01
Lupus nephritis: an overview of recent findings. Autoimmune Dis (2012) 1.00
IL-4 and many roads to lupuslike autoimmunity. Clin Immunol (2003) 0.95
Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. J Immunol (2008) 0.79
B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. Clin Immunol (2010) 0.79
EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene. Genes Chromosomes Cancer (2010) 2.81
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 2.36
A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol (2011) 2.24
Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice. Arthritis Rheum (2012) 2.21
Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus. J Rheumatol (2012) 1.97
Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology (Oxford) (2010) 1.88
Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Clin Immunol (2012) 1.74
Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol (2006) 1.63
Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance. Arthritis Rheum (2007) 1.62
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin Cancer Res (2003) 1.59
Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease. J Immunol (2009) 1.55
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice. Arthritis Rheum (2012) 1.53
Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer (2013) 1.51
Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis. J Immunol (2007) 1.49
Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol (2002) 1.49
Diffuse calcifications of the spleen: a novel association with systemic lupus erythematosus. Semin Arthritis Rheum (2010) 1.49
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol (2006) 1.43
Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum (2007) 1.42
TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol (2007) 1.42
Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum (2005) 1.41
Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. J Immunol (2009) 1.40
BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum (2005) 1.33
Necrotizing fasciitis in systemic lupus erythematosus. Semin Arthritis Rheum (2007) 1.27
Urinary TWEAK and the activity of lupus nephritis. J Autoimmun (2007) 1.21
TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine (2009) 1.20
The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Front Biosci (2004) 1.18
Role of TWEAK in lupus nephritis: a bench-to-bedside review. J Autoimmun (2012) 1.15
Metabolic disturbances associated with systemic lupus erythematosus. PLoS One (2012) 1.15
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum (2006) 1.14
Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum (2004) 1.13
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. Arthritis Rheum (2009) 1.11
Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis Res Ther (2012) 1.10
Commentary on "The risky business of studying prognosis". J Rheumatol (2013) 1.09
B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol (2011) 1.08
Lipocalin-2, TWEAK, and other cytokines as urinary biomarkers for lupus nephritis. Ann N Y Acad Sci (2007) 1.06
Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett (2008) 1.04
Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum (2006) 1.03
Urinary biomarkers in lupus nephritis. Clin Rev Allergy Immunol (2011) 1.03
Reversible posterior leukoencephalopathy in connective tissue diseases. Semin Arthritis Rheum (2006) 1.02
The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis. Autoimmun Rev (2007) 1.01
The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. J Autoimmun (2012) 1.01
Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol (2012) 0.99
Urine proteome scans uncover total urinary protease, prostaglandin D synthase, serum amyloid P, and superoxide dismutase as potential markers of lupus nephritis. J Immunol (2010) 0.99
Thyroid fine-needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer (2009) 0.99
Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis Rheum (2012) 0.98
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.97
Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J Immunol (2007) 0.95
TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis. Immunol Lett (2009) 0.94
Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol (2009) 0.94
Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Methods (2004) 0.94
Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. J Autoimmun (2013) 0.94
Metastatic adenocarcinoma of the colon and follicular lymphoma within the same lymph node: a case report and review of the literature. Int J Gastrointest Cancer (2005) 0.93
Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev (2011) 0.91
TWEAK and the progression of renal disease: clinical translation. Nephrol Dial Transplant (2014) 0.91
Disease-specific definitions of vitamin D deficiency need to be established in autoimmune and non-autoimmune chronic diseases: a retrospective comparison of three chronic diseases. Arthritis Res Ther (2010) 0.91
A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort. Arthritis Rheumatol (2014) 0.91
The pathogenesis, diagnosis and treatment of lupus nephritis. Curr Opin Rheumatol (2014) 0.90
Sex and autoantibody titers determine the development of neuropsychiatric manifestations in lupus-prone mice. J Neuroimmunol (2010) 0.90
Choroid plexus papilloma and Pierpont syndrome. J Neurosurg Pediatr (2012) 0.89
Cutaneous horn: a malignant lesion? A brief review of the literature. Dermatol Surg (2011) 0.89
The constant region affects antigen binding of antibodies to DNA by altering secondary structure. Mol Immunol (2013) 0.88
Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Autoimmun Rev (2007) 0.88
Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin. J Immunol (2006) 0.87
Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor. Arthritis Rheum (2013) 0.87
Ectopic human mesenchymal stem cell-coated scaffolds in NOD/SCID mice: an in vivo model of the leukemia niche. Tissue Eng Part C Methods (2010) 0.87
Gene expression profiling in the study of the pathogenesis of systemic lupus erythematosus. Autoimmun Rev (2004) 0.86
IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice. Biol Direct (2012) 0.86
The New York City Rheumatology Objective Structured Clinical Examination: five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity, and sensitivity to change. Arthritis Rheum (2009) 0.85
Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.85
Racial differences in gait velocity in an urban elderly cohort. J Am Geriatr Soc (2012) 0.85
Intracerebral presentation of Hodgkin disease mimicking meningioma in a young woman: case presentation with literature review. J Pediatr Hematol Oncol (2008) 0.85
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation (2013) 0.85
Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants. Clin Cancer Res (2003) 0.85
Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase. Immunol Lett (2008) 0.84
Esophageal carcinoma in children and adolescents. J Pediatr Hematol Oncol (2012) 0.84
Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors. Genes Chromosomes Cancer (2015) 0.83
A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice. J Immunol (2002) 0.83
Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1. J Clin Immunol (2006) 0.82
B-cell biology. Rheum Dis Clin North Am (2004) 0.82
Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma. J Pediatr Surg (2011) 0.81
Conservative long-term treatment of children with eosinophilic esophagitis. Ann Allergy Asthma Immunol (2012) 0.81
Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases. Clin Immunol (2012) 0.81
Improving outcomes in patients with lupus and end-stage renal disease. Semin Dial (2013) 0.80
Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma. J Pediatr Surg (2012) 0.79
Intrathoracic glial implants in a child with gliomatosis peritonei. J Pediatr Surg (2009) 0.79
Cyclooxygenase 2 mediates the antiangiogenic effect of rapamycin in Ewing sarcoma. J Pediatr Surg (2009) 0.79
Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. J Immunol (2008) 0.79
Resting tremor secondary to a pineal cyst: case report and review of the literature. Pediatr Neurosurg (2008) 0.78
High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study. J Clin Pathol (2012) 0.78
Systemic lupus erythematosus. Clin Dev Immunol (2012) 0.78
Iatrogenic spinal epidermoid cyst after lumbar puncture using needles with stylet. Pediatr Hematol Oncol (2011) 0.78
The role of anti-alpha-actinin antibodies in the pathogenesis and monitoring of lupus nephritis. Arthritis Res Ther (2009) 0.78
Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge. Semin Arthritis Rheum (2010) 0.78
Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality. J Rheumatol (2011) 0.78
JAK2 inhibition in murine systemic lupus erythematosus. Immunotherapy (2012) 0.77
Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis. JCI Insight (2017) 0.76
Controversies in rheumatism and autoimmunity. Autoimmun Rev (2011) 0.75